PBYI PUMA BIOTECHNOLOGY, INC.

Nasdaq pumabiotechnology.com


$ 4.89 $ -0.03 (-0.61 %)    

Thursday, 13-Nov-2025 15:54:25 EST
QQQ $ 607.48 $ -10.20 (-1.65 %)
DIA $ 474.68 $ -6.68 (-1.39 %)
SPY $ 671.22 $ -9.22 (-1.35 %)
TLT $ 89.47 $ -0.33 (-0.36 %)
GLD $ 382.79 $ -4.49 (-1.16 %)
$ 4.99
$ 4.91
$ 4.88 x 100
$ 4.89 x 304
$ 4.81 - $ 4.97
$ 2.32 - $ 6.12
670,356
na
251.45M
$ 0.88
$ 6.80
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-06-2025 09-30-2025 10-Q
2 08-07-2025 06-30-2025 10-Q
3 05-08-2025 03-31-2025 10-Q
4 02-27-2025 12-31-2024 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-01-2024 06-30-2024 10-Q
7 05-02-2024 03-31-2024 10-Q
8 02-29-2024 12-31-2023 10-K
9 11-02-2023 09-30-2023 10-Q
10 08-03-2023 06-30-2023 10-Q
11 05-04-2023 03-31-2023 10-Q
12 03-02-2023 12-31-2022 10-K
13 11-03-2022 09-30-2022 10-Q
14 08-04-2022 06-30-2022 10-Q
15 05-05-2022 03-31-2022 10-Q
16 03-03-2022 12-31-2021 10-K
17 11-04-2021 09-30-2021 10-Q
18 08-05-2021 06-30-2021 10-Q
19 05-06-2021 03-31-2021 10-Q
20 03-01-2021 12-31-2020 10-K
21 11-05-2020 09-30-2020 10-Q
22 08-06-2020 06-30-2020 10-Q
23 05-07-2020 03-31-2020 10-Q
24 02-28-2020 12-31-2019 10-K
25 11-07-2019 09-30-2019 10-Q
26 08-09-2019 06-30-2019 10-Q
27 05-10-2019 03-31-2019 10-Q
28 03-01-2019 12-31-2018 10-K
29 11-05-2018 09-30-2018 10-Q
30 08-09-2018 06-30-2018 10-Q
31 05-10-2018 03-31-2018 10-Q
32 03-09-2018 12-31-2017 10-K
33 11-09-2017 09-30-2017 10-Q
34 08-09-2017 06-30-2017 10-Q
35 05-10-2017 03-31-2017 10-Q
36 03-01-2017 12-31-2016 10-K
37 11-09-2016 09-30-2016 10-Q
38 08-09-2016 06-30-2016 10-Q
39 05-10-2016 03-31-2016 10-Q
40 02-29-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 puma-biotechnology-raises-fy2025-sales-guidance-from-212000m-222000m-to-220000m-223000m-vs-216500m-est

Puma Biotechnology (NASDAQ:PBYI) raises FY2025 sales outlook from $212.000 million-$222.000 million to $220.000 million-$223.00...

 puma-biotechnology-sees-q4-sales-67000m-70000m-vs-66600m-est

Puma Biotechnology (NASDAQ:PBYI) sees Q4 sales of $67.000 million-$70.000 million vs $66.600 million analyst estimate.

 puma-biotechnology-q3-adj-eps-021-beats-004-estimate-sales-54500m-beat-51000m-estimate

Puma Biotechnology (NASDAQ:PBYI) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of $0...

 puma-biotechnology-affirms-fy2025-sales-guidance-of-212000m-222000m-vs-217800m-est

Puma Biotechnology (NASDAQ:PBYI) affirms FY2025 sales outlook from $212.000 million-$222.000 million to $212.000 million-$222.0...

 puma-biotechnology-sees-q3-sales-48000m-51000m-vs-60000m-est

Puma Biotechnology (NASDAQ:PBYI) sees Q3 sales of $48.000 million-$51.000 million vs $60.000 million analyst estimate.

 puma-biotechnology-q2-adj-eps-015-beats-010-estimate-sales-4920m-miss-5075m-estimate

Puma Biotechnology (NASDAQ:PBYI) reported quarterly earnings of $0.15 per share which beat the analyst consensus estimate of $0...

 puma-biotechnology-q1-adj-eps-010-beats-002-estimate-sales-4600m-beat-4455m-estimate

Puma Biotechnology (NASDAQ:PBYI) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $(...

 hc-wainwright--co-reiterates-buy-on-puma-biotechnology-maintains-7-price-target

HC Wainwright & Co. analyst Edward White reiterates Puma Biotechnology (NASDAQ:PBYI) with a Buy and maintains $7 price t...

 puma-biotechnology-sees-q1-sales-42500m-45500m-vs-4750m-est

Puma Biotechnology (NASDAQ:PBYI) sees Q1 sales of $42.500 million-$45.500 million vs $47.50 million analyst estimate.

 puma-biotechnology-sees-fy2025-sales-212000m-222000m-vs-20790m-est

Puma Biotechnology (NASDAQ:PBYI) sees FY2025 sales of $212.000 million-$222.000 million vs $207.90 million analyst estimate.

 puma-biotechnology-q4-adj-eps-043-beats-010-estimate-sales-5910m-beat-5250m-estimate

Puma Biotechnology (NASDAQ:PBYI) reported quarterly earnings of $0.43 per share which beat the analyst consensus estimate of $0...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION